Vaccine Education Survey

Question Title

* 1. Do you administer COVID-19 vaccines?

Yes

Question Title

* 2. Which of the following COVID-19 vaccines do you have experience administering? (Select all that apply)

BNT162b2 (Pfizer)

mRNA-1273 (Moderna)

Ad26.COV2.S (Janssen)

Question Title

* 3. Rank the main sources of vaccine hesitancy among patients in your clinic.

Question Title

* 4. Which of the following immune responses do you believe can be elicited by mRNA vaccines? (Select all that apply)
^{1. Jackson LA et all N Engl J Med 2020; 383:1920-2931. 2. Doria-Rose N et al. N Engl J Med 2021; 384:2259-2261}

CD8+ T cell response [1]

CD4+ T cell response [1]

Neutralizing antibody response [1,2]

Question Title

* 5. How would you rate your understanding of how mRNA vaccines work?

1 Very unfamiliar

2 Somewhat unfamiliar

3 Somewhat familiar

4 Very familiar

1 Very unfamiliar

2 Somewhat unfamiliar

3 Somewhat familiar

4 Very familiar

Question Title

* 6. How comfortable are you explaining mRNA vaccine technology to your patients?

1 Very uncomfortable

2 Somewhat uncomfortable

3 Somewhat comfortable

4 Very comfortable

1 Very uncomfortable

2 Somewhat uncomfortable

3 Somewhat comfortable

4 Very comfortable

Question Title

* 7. Based on your understanding and/or experience, how would you rate the benefit-risk profile of COVID-19 vaccines in adolescents?

1 More risky

5 More beneficial

1 More risky

5 More beneficial

Question Title

* 8. What additional information or data would most impact your decision to use COVID-19 vaccines in adolescents? (Select all that apply)

Long-term safety data in adults

Safety data in adolescents

Efficacy data in adolescents

Other (please specify)

Question Title

* 9. Do you think vaccination of all age groups, including adolescents (12 - 17y) and children (6m - 11y; once authorized), is critical to ending the pandemic?

1 Not at all critical

2 Not very critical

3 Somewhat critical

4 Very critical

1 Not at all critical

2 Not very critical

3 Somewhat critical

4 Very critical

Question Title

* 10. Regarding mRNA vaccines, your patients are most likely to be concerned about ______? (Please rank)

Question Title

* 11. Which of the following do you believe are the major benefits of COVID-19 vaccinations? (Select all that apply)

Prevent infection

Prevent transmission

Prevent long COVID

None of the above

Question Title

* 12. Do you think your patients will be willing to receive a COVID-19 booster vaccine?

1 Not willing yet

2 Somewhat unwilling

3 Indifferent

4 Somewhat seeking

5 Actively seeking

1 Not willing yet

2 Somewhat unwilling

3 Indifferent

4 Somewhat seeking

5 Actively seeking

Question Title

* 13. What would you like to know more about booster does? (Select all that apply)

Booster dose efficacy

Booster dose safety

Data against variants of concern

Multivalent vaccinations

Monovalent variant-specific vaccine

Vaccine Education Survey

Question Title

* 1. Do you administer COVID-19 vaccines?

Question Title

* 2. Which of the following COVID-19 vaccines do you have experience administering? (Select all that apply)

Question Title

* 3. Rank the main sources of vaccine hesitancy among patients in your clinic.

Question Title

* 4. Which of the following immune responses do you believe can be elicited by mRNA vaccines? (Select all that apply)1. Jackson LA et all N Engl J Med 2020; 383:1920-2931. 2. Doria-Rose N et al. N Engl J Med 2021; 384:2259-2261

Question Title

* 5. How would you rate your understanding of how mRNA vaccines work?

Question Title

* 6. How comfortable are you explaining mRNA vaccine technology to your patients?

Question Title

* 7. Based on your understanding and/or experience, how would you rate the benefit-risk profile of COVID-19 vaccines in adolescents?

Question Title

* 8. What additional information or data would most impact your decision to use COVID-19 vaccines in adolescents? (Select all that apply)

Question Title

* 9. Do you think vaccination of all age groups, including adolescents (12 - 17y) and children (6m - 11y; once authorized), is critical to ending the pandemic?

Question Title

* 10. Regarding mRNA vaccines, your patients are most likely to be concerned about ______? (Please rank)

Question Title

* 11. Which of the following do you believe are the major benefits of COVID-19 vaccinations? (Select all that apply)

Question Title

* 12. Do you think your patients will be willing to receive a COVID-19 booster vaccine?

Question Title

* 13. What would you like to know more about booster does? (Select all that apply)

* 4. Which of the following immune responses do you believe can be elicited by mRNA vaccines? (Select all that apply)
^{1. Jackson LA et all N Engl J Med 2020; 383:1920-2931. 2. Doria-Rose N et al. N Engl J Med 2021; 384:2259-2261}